drugset
drugset / Trial / NCT04673682

A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845

NCT04673682 ↗

Phase 1 Completed 47 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverSingle-blindTreatment

Summary

A clinical trial to evaluate the pharmacokinetic profiles and safety of CKD-845.

Timeline

Start
2020-11-16
Primary completion
2022-05-17
Completion
2022-06-07

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-845 Unknown — Intramuscular
Subject D309 Unknown — Intramuscular

Indications

hypogonadism